GlassScriptPhysician profile
Edvin Telemi
NPI 1386134187
$5,909.34
in general payments reported to CMS, 2019-2025
11 companies · $1,761 in 2025
The $1,761 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $951 · 2023: $2,692 · 2024: $368 · 2025: $1,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,912 · Travel and Lodging: $1,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,912.45 |
| Travel and Lodging | $1,908.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,555.86 | 2023 | Mariner Mis, Northstar |
| Globus Medical, INC. | $931.30 | 2025 | Excelsius Gps, Canopy, Sable |
| Stryker Corporation | $809.69 | 2022 | |
| Bioventus LLC | $664.12 | 2024-2025 | Bonescalpel & Sonicone (O.R.), Sonastar |
| Si-Bone, INC. | $384.41 | 2021-2025 | |
| Centinel Spine, LLC | $159.40 | 2025 | Prodisc L |
| Depuy Synthes Sales INC. | $141.40 | 2022 | |
| Providence Medical Technology, INC. | $104.69 | 2025 | |
| Aesculap, INC. | $78.86 | 2025 | Lyoplant Onlay |
| Mimedx Group, INC. | $60.20 | 2024 | |
| Cerapedics INC. | $19.41 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edvin Telemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.